Background
Methods
Cancer | Gender | Age at diagnosis | Score |
---|---|---|---|
Breast Cancer | Female | < 30 | 11 |
Breast Cancer | Female | 30–39 | 8 |
Breast Cancer | Female | 40–49 | 6 |
Breast Cancer | Female | 50–59 | 4 |
Breast Cancer | Female | > 59 | 2 |
Breast Cancer | Male | < 60 | 13 |
Breast Cancer | Male | > 59 | 10 |
Ovarian Cancer | Female | < 60 | 13 |
Ovarian Cancer | Female | > 59 | 10 |
Pancreatic Cancer | Both | 1 | |
Prostate Cancer | Male | < 60 | 2 |
Prostate Cancer | Male | > 59 | 1 |
BRCA1 and BRCA2 analysis
Results
Patients and disease characteristics
Variable | Number/Percentage |
---|---|
Number of patients | 281 |
Number of Families | 269 |
Age (mean, years) | 47.86 (15–86) |
Positive first-degree family history for Breast and/or Ovarian cancer | 165 |
Positive personal history for Breast and/or Ovarian | 208 |
Breast cancer only | 194 |
Ovarian cancer only | 12 |
Both ovarian and breast cancer | 2 |
Mean age of BC diagnosis (years) | 47.71 |
Families carriers of Deleterious Mutation | 10 |
Nucleotide Change | AA Change | Nomenclature Protein | Number of families with history of mutation |
---|---|---|---|
Deleterious | |||
c.131G > T | p.Cys44Phe | C44F | 7 |
c.3436_3439delTGTT | p.Cys1146Leufs | 3555del4 | 5 |
c.2158G > T | p.Glu720Ter | E720X | 3 |
c.3679C > T | p.Gln1227Ter | Q1227X | 1 |
c.679G > T | p.Glu227Ter | E227X | 2 |
c.3381 T > G | p.Tyr1127Ter | Y1127X | 3 |
c.4096 + 1G > A | IVS11 + 1G > A | 1 | |
c.1039_1040delCT | p.Leu347Valfs | 1158_1159delCT | 1 |
VUS | |||
c.536A > G | p.Tyr179Cys | Y179C | |
c.1456 T > C | p.Phe486Leu | F486 L | 4 |
c.1648A > C | p.Asn550His | N550H | |
c.804C > G | p.Asn268Lys | N268K | 2 |
c.3526G > A | p.Val1176Ile | V1176I | 1 |
c.107C > A | p.Ser36Tyr | S36Y | 1 |
c.4132G > A | p.Val1378Ile | V1378I | 2 |
c.3956G > T | p.Gly1319Val | G1319 V | 1 |
c.2617 T > C | p.Ser873Pro | S873P | 1 |
c.488G > C | p.Arg163Thr | R163T | 1 |
c.346G > A | p.Glu116Lys | E116K | 1 |
c.1717_1717delT | p.Ser573HisFsX | 1863delT | 1 |
Nucleotide Change | AA Change | Nomenclature Protein | Number of families with history of mutation |
---|---|---|---|
Deleterious | |||
c.9257-1G > A | IVS24-1G > A | 3 | |
c.3189_3192delGTCA | p.Ser1064Leufs | 3417del4 | 1 |
c.426-12_426-8del5 | IVS4-12del5 | 1 | |
VUS | |||
c.8775G > C | p.Gln2925His | Q2925H | 1 |
c.1627C > A | p.His543Asn | H543N | 1 |
c.8687G > A | p.Arg2896His | R2896H | |
c.8548G > A | p.Glu2850Lys | E2850K | 2 |
c.632-5 T > C | IVS7-5 T > C | 1 | |
c.9117 + 3A > G | IVS23 + 3A > G | 1 | |
c.3131G > T | p.Cys1044Phe | C1044F | 1 |
c.7976 + 49A > G | IVS17 + 49A > G | 1 |
Mutations
NCCN guidelines and Manchester scores
Literature review of BRCA mutations in the MENA region
Region | Case selection | Gene region covered | Detection method | Reference |
---|---|---|---|---|
MENA | 173 breast cancer and ovarian cancer | All | Parallel sequencing Sanger sequencing | [17] |
Lebanon | 250 females | All | Sequencing MLPA | [2] |
Lebanon | 45 families | All | Sequencing Sanger validation | [15] |
Tunisia | 7 families | All | Sequencing | [18] |
Tunisia | 92 families | Review | [11] | |
Jordan | 100 BC females | All | BRCA sequencing | [10] |
Saudi Arabia | 818 BC patients | All | Capture or Sanger sequencing | [19] |
Morocco | 6 families - 15 patients | All | Next generation sequencing | [13] |
Morocco | 40 patients | All | Sequencing | [12] |
Morocco | 122 patients | c.1310_1313delAAGA | Sanger sequencing Next generation sequencing | [20] |
Palestine | 875 patients | BROCA panel | Parallel Sequencing | [14] |
Saudi Arabia | 310 patients | BRCA1 and BRCA2 | Next generation sequencing Sanger sequencing | [9] |
BRCA1 or 2 | Genetic Variant | Number of patients with the mutation | Reference |
---|---|---|---|
Jordan | [10] | ||
BRCA2
| c.2254_2257delGACT | 4 | |
c.6685G > T | 2 | ||
Dup exon 5–11 | 4 | ||
c.8774A > G | 2 | ||
K3416E | 2 | ||
Tunisia | |||
BRCA1
| c.211dupA | 8 | |
c.5266dupC | 5 | ||
c.1309del4 | 4 | ||
c.4041delAG | 2 | ||
c.798_799delTT | 2 families | ||
BRCA2
| c.1542_1547delAAGA | 2 | |
c.7887_7888insA | 2 | ||
c.1309del4 | 5 | ||
Morocco | |||
BRCA1
| c.798_799delTT | 2 | |
c.5062_5064delGTT | 2 | ||
BRCA2
| c.7710delA | 2 | |
c.7235insG | 7 | ||
Algeria | [13] | ||
BRCA1
| c.798_799delTT | 2 families | |
Palestine | [14] | ||
BRCA2
| c.2482delGACT | 6 | |
Lebanon | |||
BRCA1
| c.131G > T | 6 | |
BRCA2
| c.9257_1G > A | 3 | |
Saudi Arabia | [9] | ||
BRCA1
| c.4136_4137delCT | 5 | |
c.4524G > A | 5 |